SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-17-000223
Filing Date
2017-03-29
Accepted
2017-03-29 16:12:20
Documents
1
Group Members
MICHAEL JAMES BARRETTNEA PARTNERS 10, LIMITED PARTNERSHIPPETER J. BARRISSCOTT D. SANDELL

Document Format Files

Seq Description Document Type Size
1 CATALYST BIOSCIENCES, INC. - AMENDMENT #5 nea10cata13d_18055.htm SC 13D/A 182812
  Complete submission text file 0001072613-17-000223.txt   184392
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 17722356
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 1119 ST PAUL STREET BALTIMORE MD 21202 4102440115
NEW ENTERPRISE ASSOCIATES 10 L P (Filed by) CIK: 0001132326 (see all company filings)

IRS No.: 061590878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A